003017 Zhejiang Dayang Biotech Group
- 19.11
- +0.25+1.33%
Zhejiang Dayang Biotech Group News
Ocean Biotech: Announcement of Board Resolutions
Ocean Biotech: Opinions of the Supervisory Board of Zhejiang Dayang Biotechnology Group Co., Ltd. on matters related to the 14th meeting of the 5th Board of Supervisors
Ocean Biotech: Announcement of Supervisory Board Resolutions
Ocean Biotech: Verification Opinions of Caitong Securities Co., Ltd. on Zhejiang Dayang Biotechnology Group Co., Ltd.\'s Continued Use of Some Idle Raised Funds for Cash Management
Ocean Biotech: Announcement on Continuing to Use Some Idle Raised Funds for Cash Management
Ocean Biotech: Progress announcement on the use of some idle funds raised for cash management, maturity redemption, and continued cash management
Ocean Biotech: Semi-Annual Report Board Resolution Announcement
Ocean Biotech: Progress announcement on the use of some idle funds raised for cash management, maturity redemption, and continued cash management
Ocean Biotech: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Ocean Biotech: Semi-Annual Report Supervisory Board Resolutions Announcement
Zhejiang Dayang Biotech Group: Legal Opinion of Shanghai Jintiancheng Law Firm on the Implementation of 2024 Employee Stock Ownership Plan by Zhejiang Dayang Biotech Group Co., Ltd.
Zhejiang Dayang Biotech Group: Announcement on the Progress of Using Part of the Idle Raised Funds for Cash Management
Zhejiang Dayang Biotech Group: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Directors
Zhejiang Dayang Biotech Group: Zhejiang Dayang Biotech Group Co., Ltd.'s Employee Stock Ownership Plan Management Measures for 2024.
Zhejiang Dayang Biotech Group: The Supervisory Committee of Zhejiang Dayang Biotech Group Co., Ltd. reviewed and approved the 2024 Employee Stock Ownership Plan of the company.
Zhejiang Dayang Biotech Group: Announcement of the resolution of the 12th meeting of the 5th Supervisory Board.
Zhejiang Dayang Biotech Group: Announcement regarding the use of some idle raised funds for cash management and mature redemption.
Zhejiang Dayang Biotech Group: Progress announcement on using some idle raised funds for cash management maturity redemption and continuing cash management.
Zhejiang Dayang Biotech Group: Announcement regarding the use of some idle raised funds for cash management and mature redemption.
Zhejiang Dayang Biotech Group: Announcement regarding the use of some idle raised funds for cash management and mature redemption.
Analysis
Price Target
No Data
No Data